Novartis AG Stock Market Performance on January 22, 2026
Stock Price Data
- Opening Price: $145.10
- Closing Price: Near a one-year high (exact figure not specified)
- Intraday High: $146.35 (one-year high)
- Intraday Low: Not specified; one-year low recorded at $97.71
- Market Capitalization: Approximately $306.51 billion
- Price-to-Earnings (P/E) Ratio: 19.82
- PEG Ratio: 1.87
- Beta: 0.51 (lower volatility compared to broader market)
Trading Volume
Specific trading volume data for January 22, 2026, was not disclosed. However, trading activity was described as significant, indicating strong investor interest throughout the day.
Percentage Change
The stock traded up approximately 1.1% on this date. The base price for this change was not detailed in the available information.
Recent Performance and Analyst Commentary
- Novartis reported quarterly earnings per share (EPS) of $2.25, slightly below the estimated $2.26.
- Quarterly revenue came in at $14.36 billion, exceeding expectations of $13.70 billion, representing 8.5% year-over-year growth.
- Analyst sentiment was mixed with a consensus rating of “Hold” and an average target price of $119.75.
- Several analysts offered differing views:
- Bank of America recently upgraded the stock to a “Buy” rating.
- The consensus included one “Strong Buy,” five “Buy,” seven “Hold,” and two “Sell” ratings.
Institutional Trading Activities
On January 22, 2026, Wealth Enhancement Advisory Services LLC increased its stake in Novartis by 23.0%, adding 33,655 shares for a total holding of 180,188 shares valued at approximately $23.7 million. Other institutional investors such as GFG Capital LLC and Legacy Investment Solutions LLC initiated new positions in the stock, indicating heightened institutional confidence.
Market Context
The overall market on January 22, 2026, showed mixed conditions with notable fluctuations in technology stocks. Amid this backdrop, Novartis demonstrated solid performance, trading near its one-year high, supported by positive revenue results and growing institutional interest.
Summary
On January 22, 2026, Novartis AG recorded a strong market showing, trading close to its one-year high with an intraday peak of $146.35. The company’s quarterly revenue exceeded estimates, although EPS slightly missed projections, resulting in a mixed analyst outlook. Institutional investors increased their holdings, reflecting confidence in Novartis’ strategic positioning and growth prospects. Overall, the stock’s performance was robust within the context of broader market variability.
Explore more exclusive insights at nextfin.ai.
